2022 Annual Meeting Virtual Experience | S4 - Abstracts of Distinction 4

Date Tuesday 04/26/22

Time 04:00 PM - 05:08 PM EDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Scientific Platform Session

Moderator(s) Stefano Sandrone, PhD, Shadi Yaghi, MD

Topic(s) Cerebrovascular Disease and Interventional Neurology, History of Neurology, Neuro-oncology, Neuro-ophthalmology/Neuro-otology, Neuro-rehabilitation, Education, Research, and Methodology, Health Care Disparities

Learning Objectives Abstracts of distinction are top abstracts wihtin each topic presented in an oral format. Presentations are eight minutes in length with additional question and answer time during the session with the authors.

CME Available 1.00 CME credit

Program Tracks Diversity, Equity, and Inclusion

Program Materials Program Evaluations

Event Timeline
04:00 PM - 04:08 PM EDT	Speaker	Online Modules Support a Neurology Resident Teleneurology Curriculum - Pilot Data Shivika Chandra, MD, FAAN
04:08 PM - 04:16 PM EDT	Speaker	Trends in Diversity at a Single US Adult Neurology Residency Program Keiko A. Fukuda, MD
04:16 PM - 04:24 PM EDT	Speaker	Deep Learning Can Accurately Distinguish Between True Papilledema and Optic Disc Drusen On Ocular Fundus Photographs Valerie Biousse, MD
04:24 PM - 04:32 PM EDT	Speaker	Stem Cell Factor as a Novel Diagnostic Plasma Biomarker for Glioblastoma Multiforme Patients Amirhosein Kefayat, MD
04:32 PM - 04:38 PM EDT	Q&A	Q&A Shivika Chandra, MD, FAAN, Amirhosein Kefayat, MD, Keiko A. Fukuda, MD, Valerie Biousse, MD
04:38 PM - 04:46 PM EDT	Speaker	“Stranger than fiction”: the nineteenth-century media coverage of the case of Phineas Gage Manon Auffret, PhD, PharmD
04:46 PM - 04:54 PM EDT	Speaker	Loss of Regained or Spared Function after SCI (Neuroworsening): Evidence and Dimension Markus E. Harrigan
04:54 PM - 05:02 PM EDT	Speaker	Clinical pharmacy services as part of the Telehealth After Stroke Care in an underserved setting: a feasibility study Yuliya Baratt, PharmD, BCPS
05:02 PM - 05:08 PM EDT	Q&A	Q&A Manon Auffret, PhD, PharmD, Markus E. Harrigan, Yuliya Baratt, PharmD, BCPS

Faculty Disclosures
Shivika Chandra, MD, FAAN	The institution of Dr. Chandra has received research support from American Board of Psychiatry and Neurology Faculty Innovation in Education Award.
Keiko A. Fukuda, MD	Dr. Fukuda has nothing to disclose.
Valerie Biousse, MD	Dr. Biousse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gensights Biologic. Dr. Biousse has received personal compensation in the range of $0-$499 for serving as a Consultant for Neurophoenix. Dr. Biousse has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Topcon. Dr. Biousse has received publishing royalties from a publication relating to health care. Dr. Biousse has received publishing royalties from a publication relating to health care.
Amirhosein Kefayat, MD	Mr. Kefayat has nothing to disclose.
Manon Auffret, PhD, PharmD	Dr. Auffret has received personal compensation for serving as an employee of France Développement Electronique. The institution of Dr. Auffret has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Britannia. Dr. Auffret has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aguettant. Dr. Auffret has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Britannia. Dr. Auffret has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Britannia. Dr. Auffret has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aguettant. The institution of Dr. Auffret has received research support from Association France Parkinson. The institution of Dr. Auffret has received research support from Homeperf. The institution of Dr. Auffret has received research support from LVL. The institution of Dr. Auffret has received research support from University of Rennes. The institution of Dr. Auffret has received research support from Aguettant. The institution of Dr. Auffret has received research support from Linde. The institution of Dr. Auffret has received research support from Plateforme Nationale pour la recherche sur la fin de vie. Dr. Auffret has received publishing royalties from a publication relating to health care. Dr. Auffret has received publishing royalties from a publication relating to health care.
Markus E. Harrigan	Mr. Harrigan has nothing to disclose.
Yuliya Baratt, PharmD, BCPS	Dr. Baratt has nothing to disclose.
Stefano Sandrone, PhD	Dr. Sandrone has nothing to disclose.
Shadi Yaghi, MD	Dr. Yaghi has nothing to disclose.